767PPredictive factors of outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy. (23rd October 2018) - Suzuki, Y; Kan, M; Kimura, G; Umemoto, K; Watanabe, K; Sasaki, M; Takahashi, H; Hashimoto, Y; Imaoka, H; Ohno, I; Mitsunaga, S; Ikeda, M